Medical News

RSS

Nature's Sunshine Products reports 4.7% increase in first-quarter 2010 net sales

Nature's Sunshine Products, Inc., a leading manufacturer and marketer of nutritional supplements and complementary products, today reported an increase in net sales of 4.7 percent to $87.0 million for the 2010 first quarter, compared with $83.2 million for the same period in 2009.

7 May 2010

CardioMEMS completes $37.9M financing

CardioMEMS, Inc., a medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced the completion of a $37.9M financing. The financing provides the company with capital to complete the company's CHAMPION clinical trial.

7 May 2010

AHF's Magic Johnson Testing America Tour arrives in Minneapolis to offer free HIV testing

AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Minneapolis today and will offer free HIV testing, along with local partner, Siouxland Community Health Center, today in the historic 4th Street area on the south side of Mac Behr's from 7:00 PM to 12:00 Midnight.

7 May 2010

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the first quarter of fiscal 2010.

7 May 2010

HCA's first-quarter 2010 revenues increased to $7.544 billion

HCA Inc. today announced financial and operating results for its first quarter ended March 31, 2010.

7 May 2010

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

Anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it, according to a new study published in Microbiology. The work could lead to new measures to treat anthrax infection in the event of a biological warfare attack.

7 May 2010

Gift of hearing to be delivered to more than 70 underserved children, adults throughout Carolinas

Speedway Children's Charities and the National Rifle Association are partnering with the Starkey Hearing Foundation to deliver the gift of hearing to more than 70 underserved children and adults throughout the Carolinas on May 10, noon to 4pm, at Charlotte Motor Speedway.

7 May 2010

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Automated Medical Diagnostics, a startup company based in Memphis, envisions its product helping to preserve the sight of millions of people at risk of vision loss from diabetic retinopathy.

7 May 2010

Coffee-ring formation can be used to set standards for biosensor devices: UCLA researchers

The field of biosensing has recently found an unlikely partner in the quest for increased sensitivity: coffee rings. The next time you spill your coffee on a table, look at the spot left after the liquid has evaporated, and you'll notice it has a darker ring around its perimeter that contains a much higher concentration of particles than the center.

7 May 2010

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Scientists with the University of Maryland Dental School and collaborators at three other major universities will report results from the first three years of the world's largest study yet of a mysterious yet common pain syndrome involving the jaw at 8:30 a.m.on May 7 at the annual scientific meeting of the American Pain Society (APS). This year it is being held at the Baltimore Convention Center.

7 May 2010

Cytori Therapeutics to initiate European medical device approval study for Celution System

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump.

7 May 2010

Plant breeding can be used to produce new types of wheat with enhanced health benefits

Wheat products, and in particular, wholegrain products, are important sources of dietary fibre, vitamins, minerals and other components which are beneficial for human health. Analysis of a diverse range of wheat varieties within the HEALTHGRAIN project of the European Union has shown substantial variation (up to four-fold) in the content and composition of these components.

7 May 2010

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

NPWH launches ETIQ campaign to improve access to information about menopause, estrogen therapy

The National Association of Nurse Practitioners in Women's Health announced the launch of Estrogen Therapy I.Q. a campaign devoted to improving access to credible information about menopause and advances in estrogen therapy.

7 May 2010

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.

7 May 2010

USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.

7 May 2010

Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the first quarter ended March 31, 2010.

7 May 2010

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

In the last three years, a new technique for reprogramming adult cells has given scientists an easier and less controversial way to harness the power of embryonic-like stem cells to study human disease from its earliest beginnings in hopes of gleaning new insights into the root causes of disease and developing new therapies.

7 May 2010

Baby swimming helps develop balance and movement in infants, young children

Teaching babies to swim turns out to be more than just fun. Baby swimmers have better balance and are also better at grasping at things than non-swimmers. This difference persists even when children are five years old, when babies who have been taught to swim still outperform their peers, research from the Norwegian University of Science and Technology (NTNU) shows.

7 May 2010

Comprehensive education program in respiratory therapy

Teleflex Medical has announced the introduction of a comprehensive education program in respiratory therapy, designed to provide an in-depth curriculum focused on maximizing humidification and minimizing challenges through the therapeutic levels outlined in the Respiratory Pyramid of Care. The courses are accredited by the American Association for Respiratory Care.

7 May 2010

Medical News

Nature's Sunshine Products reports 4.7% increase in first-quarter 2010 net sales

CardioMEMS completes $37.9M financing

AHF's Magic Johnson Testing America Tour arrives in Minneapolis to offer free HIV testing

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

HCA's first-quarter 2010 revenues increased to $7.544 billion

Encouraging B. anthracis to unwittingly unmask itself will help eradicate the pathogen

Gift of hearing to be delivered to more than 70 underserved children, adults throughout Carolinas

Telemedical Retinal Image Analysis and Diagnosis technology permits early detection of diabetic retinopathy

Coffee-ring formation can be used to set standards for biosensor devices: UCLA researchers

First 3-year results of world's largest temporomandibular joint disorder study reported at APS meeting

Cytori Therapeutics to initiate European medical device approval study for Celution System

Plant breeding can be used to produce new types of wheat with enhanced health benefits

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

NPWH launches ETIQ campaign to improve access to information about menopause, estrogen therapy

Nile Therapeutics completes dose escalation in CD-NP Phase II study for acute decompensated heart failure

USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

Baby swimming helps develop balance and movement in infants, young children

Comprehensive education program in respiratory therapy

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News